Early vs. late reverse ventricular remodeling in patients with cardiomyopathy

被引:8
作者
Banno, Aya [1 ]
Kohsaka, Shun [1 ]
Inohara, Taku [1 ]
Koide, Kimi [1 ]
Shiraishi, Yasuyuki [1 ]
Kohno, Takashi [1 ]
Sano, Motoaki [1 ]
Yoshikawa, Tsutomu [2 ]
Fukuda, Keiichi [1 ]
机构
[1] Keio Univ, Sch Med, Div Cardiol, Tokyo, Japan
[2] Sakakibara Heart Inst, Div Cardiol, Tokyo, Japan
关键词
Cardiomyopathy; Reverse remodeling; Blood pressure; Predictors; CARDIAC RESYNCHRONIZATION THERAPY; CHRONIC HEART-FAILURE; IDIOPATHIC DILATED CARDIOMYOPATHY; CLINICAL IMPROVEMENT; JAPANESE PATIENTS; ECHOCARDIOGRAPHY; PREVALENCE; RECOMMENDATIONS; ASSOCIATION; GUIDELINES;
D O I
10.1016/j.jjcc.2015.07.021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Predictors of left ventricular reverse remodeling (LVRR) and differences in the time taken to achieve LVRR remain unclear. Methods: We consecutively registered 129 patients with severe cardiomyopathy admitted with heart failure (HF). Patients were followed for a median of 778.0 days (IQ: 457.0, 1078.0). LVRR was defined as a decrease in indexed left ventricular systolic dimension of at least 15% additional to a 25% improvement in left ventricular ejection fraction at outpatient check-up compared with discharge. LVRR accomplishment within 400 days was defined as early-LVRR opposing the remaining late-LVRR patients. Primary endpoint was a composite of all-cause mortality and HF re-hospitalization. Results: LVRR was observed in 51 patients (39.5%). Baseline predictors for LVRR were age younger than 60 years (OR, 3.27; 95% CI 1.04-10.37,p = 0.043), no history of previous HF hospitalization (OR, 0.32; 95% CI 0.12-0.86, p = 0.025), and systolic blood pressure (sBP) >100 mmHg at discharge (OR, 4.39; 95% CI 1.39-13.81, p = 0.011). Overall, there were 51 endpoint events [LVRR 11 (21.6%) vs. non-LVRR 40 (49.4%), p < 0.001 I. LVRR was a significant predictor of favorable prognosis (HR, 3.77; 95% CI 1.68-8.47, p < 0.001). Notably, 41 (80.4%) patients qualified for early-LVRR. Early-LVRR was associated with better prognosis compared with late-LVRR [early-LVRR 6 (14.6%) vs. late-LVRR 5 (50.0%), p = 0.066]. Among assessed variables, sBP >100 mmHg at discharge was a significant predictor of early-LVRR (OR, 10.87; 95% CI 1.19-100.0, p = 0.034). Conclusion: Prognosis was improved in patients who achieved LVRR. Early-LVRR tended to be an advantage in terms of long-term prognosis. Higher sBP was a predictor not only for all-LVRR but also early-LVRR. (C) 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:57 / 63
页数:7
相关论文
共 27 条
[1]   Anemia and chronic heart failure - Implications and treatment options [J].
Anand, Inder S. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (07) :501-511
[2]   Prevalence and characteristics of patients with clinical improvement but not significant left ventricular reverse remodeling after cardiac resynchronization therapy [J].
Auger, Dominique ;
van Bommel, Rutger J. ;
Bertini, Matteo ;
Delgado, Victoria ;
Ng, Arnold C. T. ;
Ewe, See Hooi ;
Shanks, Miriam ;
Marsan, Nina Ajmone ;
Mooyaart, Eline A. Q. ;
Witkowski, Tomasz ;
Poldermans, Don ;
Schalij, Martin J. ;
Bax, Jeroen J. .
AMERICAN HEART JOURNAL, 2010, 160 (04) :737-743
[3]   Reverse Remodeling and the Risk of Ventricular Tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy) [J].
Barsheshet, Alon ;
Wang, Paul J. ;
Moss, Arthur J. ;
Solomon, Scott D. ;
Al-Ahmad, Amin ;
McNitt, Scott ;
Foster, Elyse ;
Huang, David T. ;
Klein, Helmut U. ;
Zareba, Wojciech ;
Eldar, Michael ;
Goldenberg, Ilan .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (24) :2416-2423
[4]   Anemia and Iron Deficiency -- New Therapeutic Targets in Heart Failure?. [J].
Dec, G. William .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (25) :2475-2477
[5]   Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: The Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial [J].
Hori, M ;
Sasayama, S ;
Kitabatake, A ;
Toyo-Oka, T ;
Handa, S ;
Yokoyama, M ;
Matsuzaki, M ;
Takeshita, A ;
Origasa, H ;
Matsui, K ;
Hosoda, S .
AMERICAN HEART JOURNAL, 2004, 147 (02) :324-330
[6]   Effect of Left Ventricular Reverse Remodeling on Long-Term Prognosis After Therapy With Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers and β Blockers in Patients With Idiopathic Dilated Cardiomyopathy [J].
Hoshikawa, Eri ;
Matsumura, Yoshihisa ;
Kubo, Toru ;
Okawa, Makoto ;
Yamasaki, Naohito ;
Kitaoka, Hiroaki ;
Furuno, Takashi ;
Takata, Jun ;
Doi, Yoshinori L. .
AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (07) :1065-1070
[7]   Medical progress: Heart failure [J].
Jessup, M ;
Brozena, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (20) :2007-2018
[8]   Prevalence, predictors, and prognosis of reversal of maladaptive remodeling with intensive medical therapy in idiopathic dilated cardiomyopathy [J].
Kawai, K ;
Takaoka, H ;
Hata, K ;
Yokota, Y ;
Yokoyama, M .
AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (06) :671-676
[9]   Reverse remodeling in heart failure-mechanisms and therapeutic opportunities [J].
Koitabashi, Norimichi ;
Kass, David A. .
NATURE REVIEWS CARDIOLOGY, 2012, 9 (03) :147-157
[10]   Association of β-Blocker Exposure With Outcomes in Heart Failure Differs Between African American and White Patients [J].
Lanfear, David E. ;
Hrobowski, Tara N. ;
Peterson, Edward L. ;
Wells, Karen E. ;
Swadia, Tanmay V. ;
Spertus, John A. ;
Williams, L. Keoki .
CIRCULATION-HEART FAILURE, 2012, 5 (02) :202-208